Hemostats and tissue sealants market seen reaching $5.97 billion by 2030

The Business Research Company says the hemostats and tissue sealants market will rise from $4.35 billion in 2025 to $4.64 billion in 2026, then reach $5.97 billion by 2030. The forecast points to more surgeries, faster adoption of advanced sealants and wider use in minimally invasive, cardiovascular and trauma procedures.

Why it matters: - Hemostats and tissue sealants help control bleeding and seal tissue during surgery, which can improve outcomes and reduce postoperative complications. - Rising surgical volumes worldwide are expanding demand for products that support safer and faster procedures. - The market outlook signals continued demand across hospitals, surgical centers and other care settings.

What happened: - The Business Research Company published an updated global market report on hemostats and tissue sealants. - The market is projected to grow from $4.35 billion in 2025 to $4.64 billion in 2026. - The report forecasts the market will reach $5.97 billion by 2030. - North America held the largest share of the market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - Download a free sample of the report. - View the full report.

The details: - The 2025-to-2026 increase reflects a 6.7% compound annual growth rate. - The 2026-to-2030 outlook implies a 6.5% compound annual growth rate. - Past growth was tied to reliance on traditional mechanical hemostats, limited availability of synthetic sealants, more surgical interventions, better hospital infrastructure and early adoption of fibrin-based sealants. - Future growth is expected to come from next-generation tissue adhesives, more minimally invasive surgeries, more cardiovascular and trauma-related operations, and expanded research in hemostasis technologies. - Broader distribution through direct and online sales is also expected to support growth. - Hemostats either promote clot formation or physically clamp blood vessels to stop bleeding. - Tissue sealants close wounds or surgical incisions and help prevent leaks such as blood or air. - The report highlights increased use of advanced hemostatic products, synthetic and combination sealants, and greater research activity in academic and clinical settings.

Between the lines: - Surgical demand is the main market engine, and chronic disease treatment is a major reason procedures keep rising. - The shift toward minimally invasive surgery matters because these procedures often need products that can work quickly and precisely in tight operating environments. - The inclusion of online sales suggests the category is moving beyond traditional hospital procurement channels. - The report’s regional split points to North America as the current leader, but the broader coverage suggests growth opportunities remain spread across multiple markets.

What's next: - The market will likely track future surgical volumes, especially in cardiovascular, trauma and minimally invasive procedures. - Product development should continue to focus on synthetic, combination and next-generation adhesive technologies. - Academic and clinical research may play a bigger role in shaping adoption and product design. - Distribution strategies are likely to broaden as vendors use direct and online channels to reach more buyers.

The bottom line: - Hemostats and tissue sealants remain a steady-growth surgical category, with demand rising as more operations require better bleeding control and tissue closure.